UB Paderborn / Katalog / Suche / in CDI

1 – 15 von 15

Sortiert nach

Maternal treatment with oral intestinal alkaline phosphatase mitigates high fat diet-induced cognitive disorders in offspring mice

Behavioural brain research, 2020-08, Vol.392, p.112701-112701, Article 112701

2020

Link zum Volltext

Verfügbarkeit prüfen

Treatment with a Lactococcus lactis that chromosomally express E. coli cfaI mitigates salivary flow loss in a Sjögren's syndrome-like disease

Scientific reports, 2023-11, Vol.13 (1), p.19489-19489, Article 19489

2023

Link zum Volltext

Verfügbarkeit prüfen

Current Concepts for the IND-Directed Development of Microbicide Products to Prevent the Sexual Transmission of HIV

Current topics in medicinal chemistry, 2016-01, Vol.16 (10), p.1118

2016

Link zum Volltext

Verfügbarkeit prüfen

Emerging role of regulatory T cells in gene transfer

Current gene therapy, 2007-10, Vol.7 (5), p.381

2007

Link zum Volltext

Verfügbarkeit prüfen

Organ-specific protection against lipopolysaccharide-induced vascular leak is dependent on the endothelial protein C receptor

Arteriosclerosis, thrombosis, and vascular biology, 2013-04, Vol.33 (4), p.769

2013

Link zum Volltext

Verfügbarkeit prüfen

Vascular and dendritic cell coagulation signaling in sepsis progression

Journal of thrombosis and haemostasis, 2009-07, Vol.7 (Suppl 1), p.118-121

2009

Link zum Volltext

Verfügbarkeit prüfen

673. Novel Delayed-Release Formulation of an Oral β-Lactamase Prevents Gut Microbiome Damage and Attenuates Antibiotic Resistance Caused by Oral Amoxicillin/Clavulanate without Interfering with Amoxicillin Systemic Absorption in Dogs

Open forum infectious diseases, 2019-10, Vol.6 (Supplement_2), p.S307-S307

2019

Link zum Volltext

Verfügbarkeit prüfen

620. Oral β-Lactamase Therapies Prevent Microbiome Damage and Attenuate Antibiotic Resistance From IV and Oral Antibiotics in Large Animal Models of Antibiotic-Mediated Gut Dysbiosis

Open forum infectious diseases, 2018-11, Vol.5 (suppl_1), p.S226-S226

2018

Link zum Volltext

Verfügbarkeit prüfen

SYN-006, a Novel Carbapenemase, Intended to Protect the Gut Microbiome from Antibiotic-Mediated Damage May Also Reduce Propagation of Carbapenem-Resistant Pathogens

Open forum infectious diseases, 2017-10, Vol.4 (suppl_1), p.S231-S232

2017

Link zum Volltext

Verfügbarkeit prüfen

Gut Antibiotic Inactivation by Β-Lactamases Is Intended to Prevent Microbiome Damage and Attenuate Antibiotic Resistance in Large Animal Models

Open forum infectious diseases, 2017-10, Vol.4 (suppl_1), p.S232-S233

2017

Link zum Volltext

Verfügbarkeit prüfen

P2X7 receptor signaling contributes to tissue factor-dependent thrombosis in mice

The Journal of clinical investigation, 2011-07, Vol.121 (7), p.2932

2011

Link zum Volltext

Verfügbarkeit prüfen

Clinical-Stage, Oral β-Lactamase Enzyme to Prevent Clostridium difficile Infection Triggered by Antibiotic-Mediated Gut Microbiome Disruption

Open forum infectious diseases, 2016-12, Vol.3 (suppl_1)

2016

Link zum Volltext

Verfügbarkeit prüfen

75. Protease-Activated Receptor 2 as a Novel Target for Immune Modulation for AAV-Mediated Gene Transfer to Skeletal Muscle

Molecular therapy, 2006-05, Vol.13 (S1), p.S32-S32

2006

Link zum Volltext

Verfügbarkeit prüfen

1114. Antithrombotic Effects of Endogenous Expressed Activated Protein C (aPC) in Murine Models

Molecular therapy, 2005-05, Vol.11 (S1), p.S429-S429

2005

Link zum Volltext

Verfügbarkeit prüfen

879. Effects of Continuous Expression of Activated Protein C (APC) in Novel Murine Thrombosis Models

Molecular therapy, 2006-05, Vol.13 (S1), p.S338-S338

2006

Link zum Volltext

Verfügbarkeit prüfen

1 – 15 von 15

Suche als RSS-Feed

Aktive Filter

KollektionNUS Single-Journal Subscriptions

SpracheJapanisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(15)
Mit Volltextzugriff
(12)

Publikationsform

Artikel
(15)

Sprache

Englisch
(15)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Maternal treatment with oral intestinal alkaline phosphatase mitigates high fat diet-induced cognitive disorders in offspring mice

Treatment with a Lactococcus lactis that chromosomally express E. coli cfaI mitigates salivary flow loss in a Sjögren's syndrome-like disease

Current Concepts for the IND-Directed Development of Microbicide Products to Prevent the Sexual Transmission of HIV

Emerging role of regulatory T cells in gene transfer

Organ-specific protection against lipopolysaccharide-induced vascular leak is dependent on the endothelial protein C receptor

Vascular and dendritic cell coagulation signaling in sepsis progression

673. Novel Delayed-Release Formulation of an Oral β-Lactamase Prevents Gut Microbiome Damage and Attenuates Antibiotic Resistance Caused by Oral Amoxicillin/Clavulanate without Interfering with Amoxicillin Systemic Absorption in Dogs

620. Oral β-Lactamase Therapies Prevent Microbiome Damage and Attenuate Antibiotic Resistance From IV and Oral Antibiotics in Large Animal Models of Antibiotic-Mediated Gut Dysbiosis

SYN-006, a Novel Carbapenemase, Intended to Protect the Gut Microbiome from Antibiotic-Mediated Damage May Also Reduce Propagation of Carbapenem-Resistant Pathogens

Gut Antibiotic Inactivation by Β-Lactamases Is Intended to Prevent Microbiome Damage and Attenuate Antibiotic Resistance in Large Animal Models

P2X7 receptor signaling contributes to tissue factor-dependent thrombosis in mice

Clinical-Stage, Oral β-Lactamase Enzyme to Prevent Clostridium difficile Infection Triggered by Antibiotic-Mediated Gut Microbiome Disruption

75. Protease-Activated Receptor 2 as a Novel Target for Immune Modulation for AAV-Mediated Gene Transfer to Skeletal Muscle

1114. Antithrombotic Effects of Endogenous Expressed Activated Protein C (aPC) in Murine Models

879. Effects of Continuous Expression of Activated Protein C (APC) in Novel Murine Thrombosis Models

Aktive Filter

Suchergebnisse filtern